Citation: | WANG Xiaoli, WANG Zhaoya, WANG Linna, JI Hui, ZHANG Yihua, YIN Jian. Design, synthesis and evaluation of hydrogen sulfide-releasing derivatives of ring opening 3-n-butylphthalide as novel platelet aggregation inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(2): 158-162. DOI: 10.11665/j.issn.1000-5048.20160205 |
[1] |
Wang XL, Wang LN, Li TT, et al. Novel hybrids of optically active ring-opened 3-n-butylphthalide derivative and isosorbide as potential anti-ischemic stroke agents[J].J Med Chem,2013,56(7):3078-3089.
|
[2] |
Wang XL,Wang LN,Xiao S,et al.Design,synthesis and biological evaluation of hydrogen sulfide releasing derivatives of 3-n-butylphthalide as potential antiplatelet and antithrombotic agents[J].Org Biomol Chem,2014,12(31):5995-6004.
|
[3] |
Zhang Y,Wang L,Zhang LY,et al.Effects of 1-(1-hydroxypentyl)-benzoate on platelet aggregation and thrombus formation in rats[J].Drug Dev Res,2004,63(11):174-180.
|
[4] |
Wang XL,Li Y,Zhao Q,et al.Design,synthesis and evaluation of nitric oxide releasing derivatives of 3-n-butylphthalide as anti-platelet and antithrombotic agents[J].Org Biomol Chem,2011,9(16):5670-5681.
|
[5] |
Wang XL,Zhao Q,Wang XL, et al.Studies on the enantiomers of ZJM-289:synthesis and biological evaluation of antiplatelet,antithrombotic and neuroprotective activities[J].Org Biomol Chem,2012,10(45):9030-9040.
|
[6] |
Zhang Y, Tang ZH, Ren Z, et al. Hydrogen sulfide,the next potent preventive and therapeutic agent in aging and age-associated diseases[J].Mol Cell Biol,2013,33(6):1104-1113.
|
[7] |
Luo Y,Liu X,Zheng Q,et al.Hydrogen sulfide prevents hypoxia-induced apoptosis via inhibition of an H2O2-activated calcium signaling pathway in mouse hippocampal neurons[J].Biochem Biophys Res Commun,2012,425(2):473-477.
|
[8] |
Kimura K,Kimura H.Hydrogen sulfide protects neurons from oxidative stress[J].FASEB J,2004,18(10):1165-1172.
|
[9] |
Caliendo G,Cirino G,Santagada V,et al.Synthesis and biological effects of hydrogen sulfide(H2S):development of H2S-releasing drugs as pharmaceuticals[J].J Med Chem,2010,53(17):6275-6286.
|
[10] |
Li Q,Lv J,Yang MQ,et al.Effects of NBP combined with Xueshuantong on the improvement of neural function in patients with ischemic cerebral stroke[J].Chin J Biochem Pharm(中国生化药物杂志),2014,6(34):107-109.
|
[11] |
Ma HZ, Wu B, Liu SX, et al. The efficacy of the therapy of butylphathalide combined with fasudil for acute cerebral infarction and its influence on hs-CRR[J].Prog Mod Biomed(现代生物医学进展),2014,13(13):2543-2546.
|
[12] |
Xu JY.Clinical observation of butylphthalide combined with aspirin in treatment of acute watershed cerebral infarction[J].Drugs Clini(现代药物与临床),2015,30(5):535-538.
|
[13] |
Lazzarato L, Chegaev K, Marini E, et al. New nitric oxide or hydrogen sulfide releasing aspirins[J].J Med Chem,2011,54(15):5478-5484.
|
[14] |
Wang XL, Wang LN, Huang ZJ, et al. Synthesis and biological evaluation of nitric oxide releasing derivatives of 6-amino-3-n-butylphthalide as potential antiplatelet agents[J].Bioorg Med Chem Lett,2013,23(7):1985-1988.
|
[1] | SHANG Feiyang, LIU Chengbo, TAN Hongzhou, HE Bing, HE Liqin. Design, synthesis and antiplatelet aggregation activity of 3-acetyl-7-hydroxycoumarin derivatives[J]. Journal of China Pharmaceutical University, 2024, 55(3): 367-374. DOI: 10.11665/j.issn.1000-5048.2023072901 |
[2] | DAI Weiguo, TAN Hongzhou, GU Hongxia, HE Bing, HE Liqin, HUANG Peng. Design, synthesis and anti-platelet aggregation activity of paeonol oxime derivatives[J]. Journal of China Pharmaceutical University, 2022, 53(5): 535-541. DOI: 10.11665/j.issn.1000-5048.20220504 |
[3] | LI Yuyao, SONG Heng, CHENG Jian, AO Guizhen. Synthesis and biological evaluation of H2S donor ADT-OH derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(3): 276-281. DOI: 10.11665/j.issn.1000-5048.20170304 |
[4] | GAO Yang, YIN Wei, LIU Jingchao, KANG Fenghua, JIAN Yanlin, ZHOU Jinpei, HUANG Zhangjian, ZHANG Yihua. Design, synthesis and antiplatelet evaluation of tetramethylpyrazine/chalcone hybrids[J]. Journal of China Pharmaceutical University, 2017, 48(1): 23-30. DOI: 10.11665/j.issn.1000-5048.20170104 |
[5] | SUN Yinxing, WU Ying, SONG Heng, CHENG Jian, AO Guizhen. Synthesis and biological evaluation of H2S donor memantine derivatives[J]. Journal of China Pharmaceutical University, 2016, 47(5): 543-547. DOI: 10.11665/j.issn.1000-5048.20160506 |
[6] | FANG Jiangen, WANG Xuliang, LING Jingjing, YIN Wei, XU Jinyi, JI Hui, ZHANG Yihua. Synthesis and antiplatelet aggregation/antioxidant activity of 3-alkyl-benzo[c] selenophen-1(3H)-ones[J]. Journal of China Pharmaceutical University, 2015, 46(5): 552-555. DOI: 10.11665/j.issn.1000-5048.20150506 |
[7] | YANG Chunyu, HUANG Zhangjian, LING Jingjing, JI Hui, LAI Yisheng, XU Jinyi, PENG Sixun, ZHANG Yihua. Synthesis and evaluation of carbamate-isosorbide-3-n-butylphthalide ring opening derivative trihybrids as novel platelet aggregation inhibitors[J]. Journal of China Pharmaceutical University, 2013, 44(3): 202-206. DOI: 10.11665/j.issn.1000-5048.20130302 |
[8] | ZHANG Bo-yu, SHAN Jia-qi, LIU Lin, JIAO Bo, SUN Hong-bin. Synthesis and antiplatelet aggregation activities of prasugrel derivatives[J]. Journal of China Pharmaceutical University, 2011, 42(4): 305-309. |
[9] | Synthesis and anti-platelet aggregation activity of substituted (E)-1,2-diarylethene compounds[J]. Journal of China Pharmaceutical University, 2010, 41(5): 419-423. |
[10] | Synthesis and Antiplatelet Aggregation of N Acylated Tetrahydrobenzylisoquinoline[J]. Journal of China Pharmaceutical University, 1997, (5): 3+6-7. |